http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020059679-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd937db8bd37262ebe475bf5de9b244 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f627e34d1c7e70b7d2dd9c5a00444fd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b617006fcc3588667b62145cc2b46ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f9e7f514bea1082e18769bef39655b2 |
publicationDate | 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2020059679-A |
titleOfInvention | Pharmaceutical composition containing apelin receptor agonist having retinal neuroprotection |
abstract | PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing an agonist having an action of protecting retinal nerve cells damaged in diabetic retinopathy and having high selectivity for an apelin receptor. A pharmaceutical composition containing a compound represented by the following general formula (I) as an active ingredient. (R 1 is a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms; R 2 to R 4 are each independently H, or a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms; (R 5 is a substitutable phenyl group or nitrogen-containing heterocyclic group) [Selection diagram] Fig. 14 |
priorityDate | 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.